[On 2-benzolsulfonylamino-5 (beta-methoxyethoxy) pyrimidine (Glycodiazin). VII. On the mechanism of demethylation of Glycodiazin].
D000818:Animals; D002021:Buffers / Q000187:drug effects; D002248:Carbon Monoxide / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism; D004492:Edetic Acid / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007004:Hypoglycemic Agents / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis / Q000378:metabolism*; D008297:Male; D008670:Metals / Q000494:pharmacology; D008861:Microsomes / Q000378:metabolism*; D009249:NADP / Q000494:pharmacology; D010100:Oxygen / Q000494:pharmacology; D010618:Phenanthrolines / Q000494:pharmacology; D011188:Potassium; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D013449:Sulfonamides / Q000378:metabolism*
D002021:Buffers; D003486:Cyanides; D007004:Hypoglycemic Agents; D008670:Metals; D010618:Phenanthrolines; D013449:Sulfonamides; D009249:NADP; D002248:Carbon Monoxide; D004492:Edetic Acid; D011335:Proadifen; D011188:Potassium; D010100:Oxygen
Uber 2-Benzolsulfonylamino-5(beta-methoxy-äthoxy)-pyrimidin (Glycodiazin). VII. Zum Mechanismus der Entmethylierung des Glycodiazins.